Donald M. Berwick

CIK: 0001656313

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NRC

NRC HEALTH

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

NRC
NRC HEALTH
Jun 23, 2026
Award(A)
Direct
7.7K shares-
NRC
NATIONAL RESEARCH CORP
Oct 17, 2025
Award(A)
Director Stock Option (Right to Buy)
Direct
22.6K shares-
NRC
NATIONAL RESEARCH CORP
May 7, 2025
Award(A)
Director Stock Option (Right to Buy)
Direct
34.9K shares-

		Type	Shares	Price		Ownership
Jun 23, 2026	NRC NRC HEALTH	Award(A)	7,697	-	$0	Direct
Oct 17, 2025	NRC NATIONAL RESEARCH CORP	Award(A) Director Stock Option (Right to Buy)	22,625	-	-	Direct
May 7, 2025	NRC NATIONAL RESEARCH CORP	Award(A) Director Stock Option (Right to Buy)	34,917	-	-	Direct

1-3 of 3 transactions

About Berwick Donald M

Berwick Donald M (SEC CIK 0001656313) files insider reports with the SEC as Director of NRC HEALTH (NRC).

Signal8 holds 3 ownership filings by Berwick Donald M, all Form 4s, filed between May 9, 2025 and Jun 25, 2026. Those filings report 3 transactions, from May 7, 2025 to Jun 23, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Berwick Donald M's filings is in LINCOLN, NE.

Recent filings by Berwick Donald M

Jun 23, 2026: Grant or award of NRC shares (Form 4, code A).
Oct 17, 2025: Grant or award of NRC derivative securities (Form 4, code A).
May 7, 2025: Grant or award of NRC derivative securities (Form 4, code A).

Other insiders filing for NRC HEALTH (NRC)

Bhandari Parul, Director
Lockhart Stephen H, Director
NUNNELLY JOHN N, Director
Wheeler Penny Ann, Director
Rau Jason Russell, Executive Vice President
HARRISON SHANE R, EVP & Chief Financial Officer

How to read Form 4 transaction codes